Efficacy of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in HIV-1-infected Treatment-naïve Adults Without Baseline Genotyping Test (D2ARLING Study)
The purpose of this study is to evaluate the efficacy of DTG + 3TC versus DTG + TDF/FTC over 48 weeks in HIV-1 naive patients in a real life setting with no baseline HIV genotypic resistance testing available.
100 Clinical Results associated with Fundación Ideas Para La Paz
0 Patents (Medical) associated with Fundación Ideas Para La Paz
01 Mar 2021·The Lancet Planetary Health
The role of violence in planetary health
Article
Author: García, María Alejandra ; Correa-Salazar, Catalina ; Marín-Carvajal, Isabela
100 Deals associated with Fundación Ideas Para La Paz
100 Translational Medicine associated with Fundación Ideas Para La Paz